Jaguar Health, Inc.

Jaguar Health, Inc. (ticker: JAGX) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of JAGX's SEC filings surfaces 10 active risk signals, including 9 late-filing signals, and 1 auditor-change signal. JAGX reported $11.51M in revenue and -$54K for the period ending 2025-12-31, with operating cash flow of -$23.69M. Cash and equivalents stood at $968K (down 87.9% year-over-year). Total assets of $38.32M are exceeded by total liabilities of $57.01M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.